Workflow
*ST赛隆: 关于赛隆药业集团股份有限公司2025年第一次临时股东大会的法律意见书

Core Viewpoint - The legal opinion issued by Kangda Law Firm confirms the legitimacy of the procedures and results of the 2025 First Extraordinary General Meeting of Sairong Pharmaceutical Group Co., Ltd. [2][15] Group 1: Meeting Procedures - The meeting was convened in accordance with the Company Law, Securities Law, and the company's articles of association, with proper notification to shareholders [2][5] - The meeting was held on August 26, 2025, at 15:00 in Zhuhai, Guangdong Province, and included both on-site and online voting [3][5] Group 2: Attendance and Voting - A total of 89 shareholders and their proxies attended the meeting, representing 38,623,965 shares, which is 38.1421% of the total voting shares [5][6] - Online voting included 85 shareholders representing 1,989,560 shares, accounting for 1.9647% of the total voting shares [6] - The total number of small investors participating in the meeting was 87, representing 2,945,060 shares, or 2.9083% of the total voting shares [6] Group 3: Voting Results - The election of non-independent directors was conducted using a cumulative voting method, with results showing 38,925,333 votes in favor, representing 95.8433% of the total votes cast [8][10] - The voting results for independent directors also showed strong support, with votes ranging from 95.8482% to 95.9164% in favor [10][11] - A special resolution was passed with 40,596,815 votes in favor, accounting for 99.9589% of the valid votes cast [12][15]